Your browser is no longer supported. Please, upgrade your browser.
ABBV AbbVie Inc. monthly Stock Chart
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E37.41 EPS (ttm)2.23 Insider Own0.10% Shs Outstand1.48B Perf Week-6.41%
Market Cap123.54B Forward P/E8.80 EPS next Y9.49 Insider Trans9.44% Shs Float1.48B Perf Month-7.43%
Income3.32B PEG10.20 EPS next Q2.20 Inst Own73.70% Short Float4.87% Perf Quarter7.45%
Sales32.87B P/S3.76 EPS this Y4.80% Inst Trans0.99% Short Ratio9.44 Perf Half Y25.32%
Book/sh-5.55 P/B- EPS next Y6.29% ROA5.60% Target Price95.18 Perf Year-2.72%
Cash/sh7.20 P/C11.60 EPS next 5Y3.67% ROE-39.10% 52W Range62.66 - 91.99 Perf YTD-5.65%
Dividend4.72 P/FCF18.42 EPS past 5Y7.60% ROI21.80% 52W High-9.19% Beta0.92
Dividend %5.65% Quick Ratio1.00 Sales past 5Y11.80% Gross Margin77.00% 52W Low33.32% ATR1.53
Employees30000 Current Ratio1.20 Sales Q/Q3.00% Oper. Margin20.00% RSI (14)29.55 Volatility1.94% 1.60%
OptionableYes Debt/Eq- EPS Q/Q-30.00% Profit Margin9.80% Rel Volume1.73 Prev Close85.27
ShortableYes LT Debt/Eq- EarningsFeb 07 BMO Payout191.10% Avg Volume7.62M Price83.54
Recom2.20 SMA20-5.87% SMA50-5.21% SMA2007.90% Volume13,188,092 Change-2.03%
Jan-07-20Initiated RBC Capital Mkts Sector Perform $86
Dec-26-19Reiterated Cowen Outperform $90 → $98
Sep-26-19Upgrade Citigroup Neutral → Buy $87 → $90
Aug-20-19Upgrade Piper Jaffray Neutral → Overweight $80
Jun-27-19Upgrade Wolfe Research Underperform → Peer Perform
Jun-26-19Upgrade SVB Leerink Mkt Perform → Outperform $88
May-28-19Initiated Goldman Neutral
Apr-29-19Upgrade BMO Capital Markets Underperform → Market Perform
Mar-25-19Downgrade Argus Buy → Hold
Jan-23-19Initiated UBS Neutral $91
Jan-03-19Downgrade BofA/Merrill Buy → Neutral
Dec-26-18Initiated Standpoint Research Buy
Oct-22-18Reiterated SunTrust Buy $157 → $135
Oct-04-18Reiterated BofA/Merrill Buy $107 → $106
Jun-01-18Downgrade Piper Jaffray Overweight → Neutral
May-30-18Downgrade Credit Suisse Neutral → Underperform
Jan-30-18Reiterated Morgan Stanley Equal-Weight $99 → $131
Jan-29-18Downgrade Leerink Partners Outperform → Mkt Perform
Oct-30-17Reiterated Leerink Partners Outperform $108 → $107
Oct-02-17Upgrade Leerink Partners Mkt Perform → Outperform
Jan-24-20 11:05AM  What Lies Ahead for Healthcare ETFs in Q4 Earnings? Zacks
09:50AM  FORM 8.3 - ABBVIE PLC - AMENDMENT Business Wire
09:13AM  Form 8.3 - Abbvie Plc - Amendment Business Wire
07:20AM  Form 8.3 - Abbvie Plc Business Wire
Jan-23-20 06:00PM  Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments GuruFocus.com
09:21AM  The one value strategy that wasnt a disaster now favors commodity sector over techs MarketWatch
09:10AM  How Trading Your Own Retirement Can Fleece Your Financial Future - January 23, 2020 Zacks
Jan-22-20 05:45PM  AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know Zacks
10:33AM  J&J's (JNJ) Q4 Earnings Surpass Estimates, Sales Fall Short Zacks
10:08AM  FORM 8.3 - ABBVIE PLC Business Wire
09:20AM  5 Big Drug/Biotech Stocks Set to Trump Q4 Earnings Estimates Zacks
09:05AM  Simple Secrets Anyone Can Use to Reach Early Retirement - January 22, 2020 Zacks
Jan-21-20 06:13PM  Roche's (RHHBY) Lymphoma Drug Polivy Gets Approval in Europe Zacks
Jan-20-20 10:01AM  Form 8.3 - ABBVIE INC Business Wire
09:18AM  Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - January 20, 2020 Zacks
Jan-18-20 09:00AM  Social Securitys not keeping up with inflation heres what that means for you MarketWatch
Jan-17-20 09:32AM  Form 8.3 - Abbvie Plc - Amendment Business Wire
09:26AM  Retirees Should Know These 3 Facts About Required Minimum Distributions - January 17, 2020 Zacks
08:11AM  Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates Zacks
08:05AM  FORM 8.3 - ABBVIE PLC Business Wire
Jan-16-20 04:33PM  Afraid of sky-high stock valuations? These Dividend Aristocrats have yields over 3% MarketWatch
11:31AM  T. Rowe Price Equity Income Fund Invests in Utility Company CenterPoint Energy GuruFocus.com
08:21AM  Form 8.3 - ABBVIE INC - AMENDMENT Business Wire
07:38AM  Form 8.3 - Abbvie Plc Business Wire
Jan-15-20 10:24AM  Democrats Called for Cuts to Drug Prices at the Debate. The Pharma Industry Says Its Trying. Barrons.com
09:05AM  Form 8.3 - Abbvie Plc - Amendment Business Wire
08:00AM  3 Large-Cap Dividend Stocks to Buy Now for Your 2020 Portfolio Zacks
06:26AM  Form 8.3 - Abbvie Plc Business Wire
05:00AM  Top Picks 2020- AbbVie Inc. ABBV MoneyShow
Jan-14-20 02:23PM  The Extreme Risks of Trading Your Own Retirement Assets - January 14, 2020 Zacks
01:01PM  AbbVie Inc. -- Moody's announces completion of a periodic review of ratings of AbbVie Inc. Moody's
08:45AM  New Head-to-Head Phase 3 Data Show SKYRIZI (risankizumab) Superior to Cosentyx® (secukinumab) Across Primary and All Ranked Secondary Endpoints in Adults with Moderate to Severe Plaque Psoriasis at 52 Weeks PR Newswire
05:30AM  AbbVie's MAVIRET® now listed on the Newfoundland and Labrador formulary CNW Group
Jan-13-20 05:45PM  AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know Zacks
05:42PM  Chinook Therapeutics' Seattle office just got a new project American City Business Journals
09:37AM  Easy Investing Secrets to an Early Retirement - January 13, 2020 Zacks
08:00AM  AbbVie to Host Fourth-Quarter and Full-Year 2019 Earnings Conference Call PR Newswire
Jan-11-20 07:18AM  The AbbVie (NYSE:ABBV) Share Price Is Up 44% And Shareholders Are Holding On Simply Wall St.
Jan-10-20 12:08PM  7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount InvestorPlace
Jan-09-20 08:39AM  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results Benzinga
Jan-08-20 03:38PM  AbbVie to separate Botox in new aesthetics unit; Brent Saunders won't have role MarketWatch
08:00AM  AbbVie Announces Leadership Team and Creation of New Business, Allergan Aesthetics, Upon Completion of Acquisition PR Newswire
06:46AM  This basket of dividend growth stocks can help your portfolio stand out in 2020 MarketWatch
Jan-07-20 10:00AM  Simple Market Timing Strategies That Work - January 07, 2020 Zacks
10:00AM  3 Top Dividend Stocks to Maximize Your Retirement Income - January 07, 2020 Zacks
Jan-06-20 05:45PM  AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know Zacks
04:13PM  One Analyst Thinks AbbVie Is Grossly Undervalued GuruFocus.com
01:52PM  New antibiotics struggle to generate sales, pharma companies hurt Yahoo Finance Video
10:59AM  These Four Dividend Stocks Could Power NOBL in 2020 ETF Trends
09:51AM  How Trading Your Own Retirement Can Fleece Your Financial Future - January 06, 2020 Zacks
08:23AM  Amgen Stock Up in a Year on Pipeline & Biosimilar Progress Zacks
08:00AM  Merck Stock Is Flirting With A Buy Zone But Should You Buy It? Investor's Business Daily
05:00AM  Top Picks 2020- AbbVie ABBV MoneyShow
Jan-03-20 06:50PM  3 Stocks with Solid Entry Points to Consider for 2020 Zacks
05:43PM  2020 Preview: The year ahead in Bay Area biotech and health American City Business Journals
11:30AM  Is AbbVie (ABBV) Stock Outpacing Its Medical Peers This Year? Zacks
09:34AM  Want To Retire Early? Learn the Intelligent Investing Secret - January 03, 2020 Zacks
09:16AM  4 Reasons Why You Should Invest in J&J (JNJ) Stock in 2020 Zacks
09:00AM  AbbVie Stock Is Poised To Become A Top Pharma But Should You Buy It? Investor's Business Daily
08:00AM  AbbVie to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-02-20 10:08AM  Drug-Price Increases Show Business as Usual Despite Public Pressure Barrons.com
Jan-01-20 12:10PM  Why the Earnings Surprise Streak Could Continue for AbbVie (ABBV) Zacks
12:00PM  AbbVie (ABBV) Upgraded to Buy: Here's Why Zacks
11:50AM  Are Investors Undervaluing AbbVie (ABBV) Right Now? Zacks
Dec-31-19 05:45PM  AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know Zacks
Dec-30-19 08:57AM  The Zacks Analyst Blog Highlights: AbbVie, Abbott Labs, Allergan, Johnson & Johnson and Merck Zacks
Dec-29-19 12:05PM  How Did AbbVie Inc (ABBV) Perform In Comparison to Hedge Fund Favorites in 2019? Insider Monkey
Dec-27-19 04:15PM  3 Dividend-Paying Large Cap Pharma Stocks to Consider for 2020 Zacks
Dec-24-19 10:50AM  The Zacks Analyst Blog Highlights: SAP, AbbVie, Sinopec, Cigna and Intuitive Surgical Zacks
09:41AM  Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - December 24, 2019 Zacks
07:12AM  ImmunoGen Lead Drug Gets Nod for Accelerated Approval Pathway (Revised) Zacks
07:00AM  Heres to Your Health: A Decade of Drug Breakthroughs Bloomberg
Dec-23-19 05:45PM  AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know Zacks
03:09PM  Top Stock Reports for SAP, AbbVie & Sinopec Zacks
Dec-20-19 09:25AM  Key AbbVie Drug Faces Competition Worries After Head-to-Head Study Barrons.com
09:22AM  Pharma Stock Roundup: Lilly's Upbeat 2020 Outlook, FDA Nod for PFE & MRK's Drugs Zacks
08:45AM  AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes PR Newswire
08:10AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Dec-19-19 10:01AM  AbbVie's JAK Inhibitor Rinvoq Receives Approval for RA in EU Zacks
Dec-18-19 02:56PM  AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for the Combination VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia (CLL) CNW Group
10:50AM  AbbVie Receives European Commission Approval of RINVOQ (upadacitinib) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis PR Newswire
09:53AM  AbbVies Humira Sales in Europe Appear to Be Holding Up Better Than Anticipated Barrons.com
08:25AM  ImmunoGen Lead Drug Gets Nod for Accelerated Approval Pathway Zacks
Dec-17-19 03:32PM  Morphic Holding Tabbed as Likely to Develop Blockbuster Drug GuruFocus.com
Dec-16-19 05:45PM  AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know Zacks
09:18AM  How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - December 16, 2019 Zacks
Dec-13-19 07:15PM  3 Investing Facts About Required Minimum Distributions You Need to Know - December 12, 2019 (Revised) Zacks
06:40PM  Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - December 11, 2019 (Revised) Zacks
12:19PM  Biotech Stocks Burn A Hole In Big Pharma's Pocket; Look For More Mergers In 2020 Investor's Business Daily
11:44AM  5 Cheap Dividend Stocks With High Yields And Annual Increases InvestorPlace
09:45AM  Retirees Should Know These 3 Facts About Required Minimum Distributions - December 13, 2019 Zacks
06:00AM  Walgreens, AbbVie, and 3 Other Dividend Aristocrat Stocks That Have Lagged the Market This Year Barrons.com
Dec-12-19 04:57PM  Seattle Genetics' Cancer Study Boosts Prospects, Takeover Appeal GuruFocus.com
02:00PM  AbbVie's 2019 Points to the End of the Efficient Market Thesis - Cramer TheStreet.com
11:03AM  The Zacks Analyst Blog Highlights: Novartis, AbbVie, Sanofi, Pioneer Natural Resources and Aqua America Zacks
09:38AM  3 Investing Facts About Required Minimum Distributions You Need to Know - December 12, 2019 Zacks
05:00AM  Should We Worry About AbbVie Inc.'s (NYSE:ABBV) P/E Ratio? Simply Wall St.
Dec-11-19 03:32PM  Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - December 11, 2019 Zacks
02:42PM  Vertex's Kalydeco Gets EU Approval to Treat CF in Infants Zacks
02:15PM  Top Research Reports for Novartis, AbbVie & Sanofi Zacks
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. It offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, it offers AndroGel, a testosterone replacement therapy; CREON, a pancreatic enzyme therapy; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide molecule gonadotropin-releasing hormone antagonist. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; Calico Life Sciences LLC; Cystic Fibrosis Foundation; Dragonfly Therapeutics, Inc.; and Pan-Canadian Pharmaceutical Alliance. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHMOND TIMOTHY J.EVP, Chief HR OfficerSep 27Sale75.0215,5151,163,8730Oct 01 05:52 PM
Schumacher Laura JVice ChairmanSep 16Buy70.4225,0001,760,523164,838Sep 18 04:25 PM
Donoghoe NicholasSVP, Enterprise InnovationAug 29Buy66.197,525498,05713,090Aug 30 04:08 PM
Stewart Jeffrey RyanSVP, US Commercial OperationsAug 16Buy64.4415,5521,002,16965,304Aug 20 04:16 PM
AUSTIN ROXANNE SDirectorAug 01Buy65.6625,0001,641,400117,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 31Buy66.0230,0001,980,69092,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 30Buy66.3510,000663,50062,114Jul 31 04:46 PM
Gosebruch Henry OEVP, Chief Strategy OfficerJul 29Buy67.2830,0002,018,38575,763Jul 31 04:46 PM
AUSTIN ROXANNE SDirectorJun 26Buy67.5011,500776,25052,114Jun 28 04:47 PM
CHASE WILLIAM JEVP, Finance & AdministrationJun 26Buy67.3030,4002,045,920169,552Jun 28 04:47 PM
RAPP EDWARD JDirectorJun 26Buy67.307,500504,75030,662Jun 28 04:48 PM
Durkin Brian LVP, ControllerMar 25Sale79.6947537,8539,121Mar 25 04:34 PM
Schumacher Laura JVice ChairmanMar 14Sale80.0025,0002,000,000139,838Mar 15 05:53 PM
SALEKI-GERHARDT AZITAEVP, OperationsMar 05Sale79.0315,7971,248,48093,312Mar 06 05:03 PM